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Abstract: 6p electrocyclization has attracted interest in organic
synthesis because of its high stereospecificity and atom
economy in the construction of versatile 5–7-membered cycles.
However, examples of asymmetric 6p electrocyclization are
quite scarce, and have to rely on the use of chiral organo-
catalysts, and been limited to pentadienyl-anion- and triene-
type 6p electrocyclizations. Described herein is a zinc-cata-
lyzed formal [4+3] annulation of isoxazoles with 3-en-1-ynol
ethers via 6p electrocyclization, leading to the site-selective
synthesis of functionalized 2H-azepines and 4H-azepines in
good to excellent yields with broad substrate scope. Moreover,
this strategy has also been used to produce chiral 2H-azepines
with high enantioselectivities (up to 97:3 e.r.). This protocol not
only is the first asymmetric heptatrienyl-cation-type 6p electro-
cyclization, but also is the first asymmetric reaction of
isoxazoles with alkynes and the first asymmetric catalysis
based on ynol ethers.
Introduction
Electrocyclic reaction of open chain conjugated p-systems
has proven to be a powerful tool in organic synthesis in the
past decades.[1] Among these electrocyclizations, 6p electro-
cyclization has attracted particular attention because of its
high stereospecificity and atom economy in the construction
of versatile 5–7-membered cycles.[2] Generally, it can be
divided into three types: pentadienyl anion, triene, and
heptatrienyl cation (Scheme 1A). However, compared with
other two types of 6p electrocyclization, the heptatrienyl-
cation type tends to be much more difficult due to its high
energy state.[3] Moreover, catalytic asymmetric 6p electro-
cyclization has been rarely explored.[4] In 2009, the group of
List disclosed a chiral phosphoric acid (CPA)-catalyzed
cycloisomerization of a,b-unsaturated hydrazones to produce
pyrazolines in high enantioselectivities,[4a] which represents
the first example of a catalytic asymmetric 6p electrocycliza-
tion (Scheme 1B). Almost at the same time, Smith and co-
workers also demonstrated an asymmetric pentadienyl-anion
type 6p electrocyclization, or Mannich-like 5-endo-trig pro-
cess, by employing cinchona alkaloid-derived quaternary
ammonium salt as chiral counterion for the synthesis of
enantioenriched indolines.[4b] Such an asymmetric protocol
has also been nicely exploited by Zhou and co-workers
through asymmetric triple relay catalysis involving palladium,
Brønsted acid, and bifunctional chiral Brønsted base/hydro-
gen bond donor catalysis.[4c] In 2013, Rueping and co-workers
developed an elegant protocol for the CPA-catalyzed enan-
Scheme 1. Asymmetric 6p electrocyclization.
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tioselective synthesis of 1,4-dihydropyridazines via asymmet-
ric triene-type 6p electrocyclization.[4d] Despite these signifi-
cant advances, the above asymmetric 6p electrocyclizations
have to rely on the use of chiral organocatalysts, such as chiral
Brønsted acids, chiral ammonium salts, and chiral Brønsted
base/hydrogen bond donor catalysts, and have so far been
limited to pentadienyl-anion- and triene-type 6p electro-
cyclizations, which deliver the corresponding 5- and 6-
membered cyclic products.
In 2015, our group disclosed a gold-catalyzed formal [3+2]
annulation between isoxazoles[5] and ynamides via presum-
able a-imino gold carbenes,[6a] which is both the first atom-
economical generation of a-imino metal carbenes through
alkyne amination and the first reaction of isoxazoles with
alkynes. On the basis of this, the formal [5+2] and [4+2]
annulations of isoxazoles with ynamides and ynol ethers were
also achieved by employing platinum as the catalyst.[6b] After
that, catalytic reactions of isoxazoles with alkynes have been
extensively studied by Hashmi and co-workers,[7] Liu and co-
workers,[8] and others,[9] and a gold-catalyzed formal [4+3]
annulation of 3-en-1-ynamides with isoxazoles to form 4H-
azepines via a presumable 6p electrocyclization has also been
demonstrated by Liu and co-workers very recently.[8d] This
strategy can not only lead to the divergent synthesis of a range
of synthetically useful N-containing heterocycles, but also
provide an efficient and atom-economical way for the N,O-
functionalizations of alkynes. In spite of these efforts, these
reactions have been mostly limited to noble-metal catalysts,
and, to our knowledge, the catalytic asymmetric reaction of
isoxazoles with alkynes has not been reported to date.
Compared with the ynamide chemistry,[10] transformations
involving ynol ethers have traditionally been far less exploit-
ed.[11] In particular, asymmetric catalysis based on ynol ethers
has not yet been reported. As a continuation of our work on
developing heterosubstituted alkynes for heterocycle syn-
thesis,[12] we herein disclose a zinc-catalyzed formal [4+3]
annulation of isoxazoles with 3-en-1-ynol ethers via hepta-
trienyl-cation-type 6p electrocyclization, leading to the prac-
tical, site-selective, and atom-economical synthesis of valua-
ble 2H-azepines and 4H-azepines in generally good to
excellent yields with broad substrate scope (Scheme 1C).[13]
Moreover, such an asymmetric formal [4+3] annulation[14]
with high enantioselectivities has also been achieved by
employing chiral bisoxazoline (BOX) as a ligand. Important-
ly, this protocol not only is the first asymmetric 6p electro-
cyclization via a heptatrienyl-cation intermediate, but also the
first asymmetric reaction of isoxazoles with alkynes and the
first asymmetric catalysis based on ynol ethers. Theoretical
calculations provide further evidence for the feasibility of the
proposed mechanism. In this article, we report the results of
our detailed investigations on this zinc-catalyzed formal [4+3]
annulation, including substrate scope, synthetic applications,
and mechanistic studies.
Results and Discussion
We initiated our study by using readily prepared 3-en-1-
ynol ether 1a and commercially available 3,5-dimethylisox-
azole 2a as model substrates (Table 1). To our delight, the
desired 2H-azepine 3 a containing an exocyclic double bond
was obtained in 61% yield with excellent diastereoselectivity
(d.r.> 20/1, determined by crude 1H NMR spectroscopy)
under previous zinc-catalyzed reaction conditions (Table 1,
Entry 1).[15] Importantly, neither the 1,5-cyclization[6a, 15b] nor
1,7-cyclization[6b] product was detected. Of note, other non-
noble metal catalysts and Brønsted acid catalysts, such as
HNTf2 and HOTf, failed to catalyze this reaction, and 1a was
decomposed in all these cases (Table 1, Entries 2–6). Subse-
quent screening of other zinc salts led to slightly decreased
yields (Table 1, Entries 7 and 8). Gratifyingly, the use of
NaBArF4 (30 mol%) as additive significantly improved the
reaction yield (Table 1, Entry 9), and 81 % yield of 2H-
azepine 3 a was achieved in the presence of both NaBArF4
(30 mol %) and racemic BOX ligand L (24 mol%) as addi-
tives (Table 1, Entry 10). Furthermore, the use of other
solvents, such as DCM and PhCF3, led to slightly decreased
yields (Table 1, Entries 12 and 13). Finally, it should be
mentioned that NaBArF4 alone could not catalyze this
reaction (Table 1, Entry 14), whereas low efficiency was
observed catalyzed by typical gold catalysts (Table 1, En-
tries 15 and 16).[16]
Having established the optimized reaction conditions
(Table 1, Entry 10), we next investigated the substrate scope
of this reation, as shown in Table 2. The reaction of cyclo-
hexenyl-substituted ynol ether 1a with different 3-alkyl-sub-
stituted isoxazoles (R2 = alkyl) 2 proceeded smoothly to
Table 1: Optimization of reaction conditions.[a]
Entry Catalyst Reaction conditions Yield [%][b]
1 Zn(OTf)2 DCE, 5 b MS, RT, 24 h 61
2 Cu(OTf)2 DCE, 5 b MS, RT, 24 h <1
3 Yb(OTf)3 DCE, 5 b MS, RT, 24 h <1
4 Sc(OTf)3 DCE, 5 b MS, RT, 24 h <1
5 HNTf2 DCE, 5 b MS, RT, 24 h <1
6 HOTf DCE, 5 b MS, RT, 24 h <1
7 ZnCl2 DCE, 5 b MS, RT, 24 h 55
8 ZnBr2 DCE, 5 b MS, RT, 24 h 46
9[c] Zn(OTf)2/NaBAr
F
4 DCE, 5 b MS, RT, 12 h 75
10[c,d] Zn(OTf)2/NaBAr
F
4/L DCE, 5 b MS, RT, 12 h 81
11[c,d] ZnCl2/NaBAr
F
4/L DCE, 5 b MS, RT, 12 h 78
12[c,d] Zn(OTf)2/NaBAr
F
4/L DCM, 5 b MS, RT, 24 h 71
13[c,d] Zn(OTf)2/NaBAr
F
4/L PhCF3, 5 b MS, RT, 24 h 74
14 NaBArF4 DCE, 5 b MS, RT, 24 h <1
15 IPrAuNTf2 DCE, 5 b MS, RT, 12 h 40
16 PPh3AuNTf2 DCE, 5 b MS, RT, 12 h 38
[a] Reaction conditions: 1a (0.1 mmol), 2a (0.3 mmol), Zn(OTf)2
(0.02 mmol), solvent (2 mL), 5 b MS (MS= molecular sieve, 75 mg), RT,
12–24 h, in Schlenk tubes. [b] Measured by 1H NMR spectroscopy using
diethyl phthalate as the internal standard. [c] 30 mol% of NaBArF4 was
added. [d] 24 mol% of L was added. NaBArF4 =sodium tetrakis[3,5-
bis(trifluoromethyl)phenyl] borate, DCE =1,2-dichloroethane.
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furnish various 2H-azepines 3 in moderate to excellent yields.
For instance, different dialkyl-substituted isoxazoles compris-
ing functional groups (for example, benzyl, alkenyl, protected
hydroxyl) were suitable substrates for this tandem annulation,
affording the corresponding 2H-azepines 3a–3 f in 63–82%
yields. Then, various 5-aryl-substituted isoxazoles bearing
both electron-donating and electron-withdrawing groups on
the aromatic ring occurred efficiently, allowing the assembly
of the desired products 3g–3k with yields ranging from 67%
to 77%. Furthermore, the reaction was also extended to 3-
ethyl-substituted isoxazoles (R2 = ethyl) to produce the
expected 2H-azepines 3 l–3o that have a trisubstituted olefin
moiety with excellent Z/E selectivity (> 20:1) in 60–75%
yields. Further to isopropyl 3-en-1-ynol ethers, other alkyl-
substituted 3-en-1-ynol ethers were also readily tolerated,
leading to products 3p–3r in 68–81 % yields. Next, other ring
systems on 3-en-1-ynol ethers (for example, cyclopentenyl,
cycloheptenyl) were also applicable substrates for this
reaction, thus delivering the desired 2H-azepines 3s–3 u in
43–76% yields. Gratifyingly, various fully substituted isoxa-
zoles were also compatible with this annulation, and the
corresponding 2H-azepines 3v–3af containing an all-carbon
quaternary stereocenter were formed in generally moderate
to excellent yields. Notably, functional groups, such as CF3
and ester group, were also tolerated. Apart from 4-aryl-
substituted isoxazoles, naphthyl- and heteroaryl-substituted
isoxazoles were transformed successfully in moderate to good
yields. 2H-azepines 3aj and 3ak were also obtained efficiently
from the corresponding trimethyl- and diphenyl-substituted
isoxazoles. Importantly, neither the 1,5-cyclization[6a, 15b] nor
1,7-cyclization[6b] was observed and excellent diastereoselec-
tivities (> 20/1) were achieved in all cases. Finally, a gram-
scale reaction of 1a and 2a was carried out in the presence of
10 mol% of Zn(OTf)2 and 15 mol% of NaBAr
F
4, providing
1.10 g of the desired 3a in 72% yield. The relative config-
uration of 3ag was confirmed by X-ray diffraction analysis
(Figure 1)[17] while the relative configuration of 3p was
established by its derivative.[16] Of note, our attempts to
synthesize the acyclic 3-en-1-ynol ethers failed probably due
to the fact that these ynol ethers are extremely unstable.
The treatment of cyclohexenyl-substituted ynol ethers 1
with 3-aryl-substituted isoxazoles 2 was then explored under
the above zinc catalysis. Interestingly, only 4H-azepines 4
were produced under the similar reaction conditions. As
shown in Table 3, this cascade annulation proceeded smoothly
with a diverse array of 3-aryl-substituted isoxazoles 2 bearing
electron-deficient and electron-rich groups on the aryl ring,
Figure 1. Structure of compound 3ag in its crystal. Thermal ellipsoids
are shown at 50% probability.
Table 2: Reaction of enynol ethers 1 with 3-alkyl-substituted isoxazoles
2.[a]
[a] Reaction conditions: 1 (0.2 mmol), 2 (0.6 mmol), Zn(OTf)2
(0.04 mmol), NaBArF4 (0.06 mmol), L (0.048 mmol), DCE (4 mL), 5 b
MS (150 mg), RT, 12 h, in Schlenk tubes. Yields are those for the isolated
products. [b] 6.0 mmol scale, 10 mol% of Zn(OTf)2, 15 mol% of
NaBArF4 and 12 mol% of L were used; [1a] = 0.1m, 12 h.
TBS = tbutyldimethylsilyl, Boc = tbutoxycarbonyl.
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and the corresponding 4H-azepines 4a–4j were isolated in
moderate to good yields.
After accomplishing the above zinc-catalyzed formal
[4+3] annulation, we tried to establish the catalytic asym-
metric version of this reaction. As summarized in Table 4, we
were delighted to find that the expected 2H-azepine 3a could
be furnished with the e.r. of 60:40–62:38 by using Py-
BOX L1,L2 as the chiral ligands (Table 4, Entries 1 and 2).
Encouraged by this preliminary result, we next investigated
different kinds of chiral BOX ligands. Various bidentate
oxazoline ligands L3–L7 were then screened (Table 4, En-
tries 3–7), and it was found that the enantioselectivity was
significantly improved by employing biphenyl-substituted
BOX ligand L5 (Table 4, entry 5) and aryl-BOX ligands L6
and L7 with large steric hindrance (Table 4, Entries 6 and 7).
In the presence of 3,5-di(2-naphthyl)-substituted BOX L7 as
the chiral ligand, the desired 2H-azepine 3a was obtained in
68% yield with 88:12 e.r. (Table 4, Entry 7). Subsequent
screening of other BOX ligands (Table 4, Entries 8 and 9),
such as diphenylamine-linked BOX L8 and spiro-BOX L9,
and different solvents, including toluene, Et2O, and THF
(Table 4, Entries 10–12), failed to further improve the enan-
tioselectivity. To our delight, a significant temperature effect
was observed (Table 4, Entries 13 and 14), and lowering the
reaction temperature to @10 8C allowed for the isolation of
3a-ent in 70 % yield with the e.r. of 95:5 (Table 4, Entry 14).
Of note, excellent diastereoselectivity (> 20:1) was achieved
in all cases. Attempts to decrease the catalyst loading to
10 mol% were not successful probably due to the fact the
ynol ether would undergo decomposition during the pro-
longed reaction time (5 days).
With the optimal reaction conditions in hand (Table 4,
Entry 14), we also studied the scope of this enantioselective
annulation reaction (Table 5). First, it was found that various
3,5-disubstituted isoxazoles with a substituent at the 5-
position (for example, alkyl, phenyl) served as appropriate
substrates to afford the corresponding enantioenriched 2H-
azepines in good yields with the e.r. of 93:7–97:3. Next, 3-
ethyl-substituted isoxazoles were able to undergo smooth
annulation to furnish the desired products 3 l-ent (62%, 93:7
e.r.) and 3m-ent (61 %, 96:4 e.r.). Furthermore, cyclohepten-
yl-substituted ynol ether was also accommodated to provide
the desired product 3t-ent in 56 % yield and e.r. of 92:8.
Moreover, this asymmetric annulation was applied to fully
substituted isoxazoles, delivering the desired 2H-azepines
Table 4: Optimization of conditions for the asymmetric formal [4+3]
annulation.[a]
Entry L Reaction conditions Yield [%][b] e.r.[c]
1 L1 DCE, RT, 12 h 75 60:40
2 L2 DCE, RT, 12 h 78 62:38
3 L3 DCE, RT, 3 h 77 71.5:28.5
4 L4 DCE, RT, 3 h 81 68:32
5 L5 DCE, RT, 3 h 75 82:18
6 L6 DCE, RT, 3 h 72 86:14
7 L7 DCE, RT, 3 h 68 88:12
8 L8 DCE, RT, 72 h <1 –
9 L9 DCE, RT, 2 h 20 62.5:37.5
10 L7 toluene, RT, 8 h 38 86:14
11 L7 Et2O, RT, 72 h 32 88:12
12 L7 THF, RT, 72 h <1 –
13 L7 DCE, 0 8C, 24 h 67 92:8
14 L7 DCE, @10 8C, 48 h 70 95:5
[a] Reaction conditions: 1a (0.1 mmol), 2a (0.3 mmol), Zn(OTf)2
(0.02 mmol), NaBArF4 (0.03 mmol), L (0.024 mmol), solvent (2 mL), 5 b
MS (75 mg), @10 8C-RT, 3–72 h, in Schlenk tubes. [b] Measured by
1H NMR using diethyl phthalate as the internal standard. [c] Determined
by HPLC analysis.
Table 3: Reaction of enynol ethers 1 with 3-aryl-substituted isoxazole-
s 2.[a]
[a] Reaction conditions: 1 (0.2 mmol), 2 (0.6 mmol), Zn(OTf)2
(0.04 mmol), NaBArF4 (0.06 mmol), L (0.048 mmol), DCE (4 mL), 5 b
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bearing a chiral all-carbon quaternary stereocenter with high
enantioselectivities in moderate to good yields. For instance,
substitutions at the para or meta position of the aryl ring of the
fully substituted isoxazoles had little effect on the asymmetric
annulation, and the desired products were formed in 46–75%
yields with the e.r. of 90:10–96:4. Finally, the naphthyl- and
thienyl- substituted isoxazoles were also suitable substrates
for this annulation to yield the desired 3ag-ent (55 %, 93.5:6.5
e.r.) and 3ai-ent (52 %, 94:6 e.r.), respectively. Again,
excellent diastereoselectivities (> 20/1) were obtained in all
cases. Our attempts to extend the reaction to 3-aryl-sub-
stituted isoxazoles only led to the decomposition of ynol
ethers in the presence of chiral catalysts.[16]
Further synthetic transformations of the as-synthesized
chiral 2H-azepine 3a-ent were then explored, as shown in
Scheme 2. First, oxidation of the exocyclic double bond of 3a-
ent, which could be obtained on a preparative scale in 64%
yield, afforded the dicarbonyl product 5a in 71% yield while
reduction of the carbonyl group by NaBH4 led to the
corresponding alcohol 5b in 88 % yield. Of note, exocyclic
double bond would undergo isomerization in the latter case.
Furthermore, the reaction of 3a-ent and 3aa-ent with
tetracyanoethylene resulted in the formation of 5c and 5 i in
almost quantitative yield, respectively. The absolute config-
uration of 5 i was confirmed by X-ray diffraction analysis
(Figure 2),[17] which also determined the absolute configura-
tion of chiral 2H-azepines 3. Moreover, facile hydrolysis of 3a
under the acidic reaction conditions could afford the valuable
7-membered-lactam 5d, found in a large number of pharma-
ceutically active molecules,[18] and notable is that racemiza-
tion occurred in this process. Finally, it was found that the
exocyclic double bond of 3a-ent could selectively introduce
different amount of halogens in the presence of NBS or NIS,
thus providing functional mono- or di-bromoalkene and
mono- or di-iodoalkene 5e–5h in good to excellent yields,
which could be readily further functionalized. Prominently,
excellent diastereoselectivity (> 20:1) and excellent Z/E
selectivity (> 20:1) were obtained in all these transformations,
and almost complete chirality-transfer was observed except
for the formation of 5d.
Scheme 2. Preparative-scale synthesis and further transformations.
Reagents and conditions: i) RuCl3 (3 mol%), NaIO4 (3 equiv), MeCN/
H2O, RT, 5 min; ii) NaBH4 (2 equiv), MeOH, RT, 2 h; iii) tetracyano-
ethylene (1.2 equiv), RT, 10 min; iv) LiCl (5 equiv), TsOH (5 equiv),
DMF, 120 8C, 30 min; v) NBS (1 equiv), DCM, RT, 30 min; vi) NIS
(1 equiv), DCM, RT, 30 min; vii) NBS (2.2 equiv), DCM, RT, 30 min;
viii) NIS (2.2 equiv), DCM, RT, 30 min.
Table 5: Scope of the asymmetric formal [4+3] annulation of enynol
ethers 1 with 3-alkyl-substituted isoxazoles.[a]
[a] Reaction conditions: 1 (0.2 mmol), 2 (0.6 mmol), Zn(OTf)2
(0.04 mmol), NaBArF4 (0.06 mmol), L7 (0.048 mmol), DCE (4 mL), 5 b
MS (150 mg), @10 8C, 48 h, in Schlenk tubes. Yields are those for the
isolated products. The e.r. values are determined by HPLC analysis.
[b] RT, 8 h.
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Based on the above experimental observations and the
density functional theory (DFT) calculations, a plausible
reaction mechanism has been presented in Scheme 3 to
account for the selectivity of this Zn-catalyzed annulation of
1a with 2a. Initially, enynol ether 1a coordinates with ZnII via
the triple bond to form the intermediate A, and this process is
exergonic by 3.9 kcalmol@1. Then, nucleophilic attack of
isoxazole 2a to the ZnII-activated enyne occurs via the
transition state TS-B to form vinyl zinc intermediate B by
overcoming a barrier of 10.4 kcalmol@1. Subsequent ring
opening of isoxazole affords vinyl-stabilized carbocation
intermediate C1[15, 19] with a Z-configured double bond, which
is thermodynamically more favorable than intermediate C2
with E-configuration, via transition state TS-C with an
activation energy of 11.2 kcalmol@1. It is notable that the
stabilization of intermediate C1 can be attributed to the
coordination of the carbonyl oxygen to the zinc atom
according to the calculations and the Cartesian coordinates.[16]
Stereospecific 6p electrocyclization occurs to afford trans
seven-membered intermediate D1, which is thermodynami-
cally more favorable than cis D1.[16] Finally, protodemetalla-
tion delivers the desired 2H-azepine 3a. Of note, the for-
mation of the corresponding 4H-azepine 4aa is thermody-
namically unfavorable. Meanwhile, we also considered the
other cyclization scenarios, such as 4p-electrocyclization via
TS-D2,[6a, 15b] O-6p-electrocyclization via TS-D3,[6b] and O-8p-
electrocyclization via TS-D4, the activation barriers for these
three situations are 15.5, 11.6, and 29.7 kcalmol@1, respec-
tively. Thus, the activation barrier for 1,5-cyclization and 1,9-
cyclization are higher than the 1,7-cyclization via TS-D1 with
an activation energy of 12.1 kcal mol@1, while the 1,7-cycliza-
tion via TS-D3 is highly reversible. In the cases where chiral
zinc complexes are employed, the reaction would undergo
enantioselective 6p electrocyclization to eventually produce
the chiral 2H-azepines.
Conclusion
In summary, we have developed an efficient zinc-cata-
lyzed formal [4+3] annulation of isoxazoles and 3-en-1-ynol
ethers via 6p electrocyclization, thus allowing the practical
and site-selective synthesis of functionalized 2H-azepines and
4H-azepines in generally good to excellent yields with broad
substrate scope. Moreover, we have achieved the asymmetric
formal [4+3] annulation to produce valuable chiral 2H-
azepines with high enantioselectivities (up to 97:3 e.r.), which
is not only the first example of asymmetric heptatrienyl cation
type 6p electrocyclization, but also the first asymmetric
reaction of isoxazoles with alkynes and the first asymmetric
catalysis based on ynol ethers.[20] Furthermore, the mecha-
nistic rationale for this annulation is well supported by DFT
calculations. The development of non-noble metal-catalyzed
asymmetric reaction of heterosubstituted alkynes for hetero-
cycle synthesis and mechanistic investigations are the subjects
of ongoing research in our laboratory.
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Figure 2. Structure of compound 5 i in its crystal. Thermal ellipsoids
are shown at 50% probability.
Scheme 3. Plausible reaction mechanism and theoretical studies for
the ZnII-catalyzed annulation reaction for the synthesis of 2H-azepi-
ne 3a. Relative free energies of key intermediates and transition states
were given in kcalmol@1 and all calculations were computed at the
M06 level of theory in DCE solvent at 298 K. Key bond lengths are
shown in italic (unit: b).
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